AbbVie director resigns to become CEO of Align Technology
Alpha Vantage · StreetInsider · · AI-summarised by FinFlash
Jennifer L. Davis has resigned from AbbVie Inc.'s Board of Directors, effective November 2, 2026. Her resignation is due to her recent appointment as Chief Executive Officer of Align Technology, Inc. The filing states that her departure is not a result of any disagreement with AbbVie's operations or policies.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.